Iodide

Iodide

SCHEMBL5543954

CC[N+](CC)(CC)CCOC(CNC(=O)OC(C)(C)C)c1ccccc1.[I-]

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 2/20 0.49
CHRM3 known ✓ P20309 2/20 0.49
CHRM2 P08172 1/20 0.49
SYK P43405 1/20 0.44
CTSK P43235 3/20 0.41
CTSS P25774 1/20 0.41
IDO1 P14902 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
CHRNB2 P17787 4/20 0.38
CHRNB4 P30926 4/20 0.38
CHRNA3 P32297 4/20 0.38
CHRNA7 P36544 4/20 0.38
CHRNA4 P43681 4/20 0.38
CHRNA10 Q9GZZ6 1/20 0.38
CHRNA9 Q9UGM1 1/20 0.38
ATM Q13315 1/20 0.37
MALT1 Q9UDY8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14365126 0.99 CHRM1 (0.47) CHRM1CHRM3CHRM2SYKCTSK
SCHEMBL31068513 0.83 SYK (0.45) SYKCTSKCTSSIDO1NPC1
SCHEMBL5543981 0.83 SYK (0.46) SYKCTSKCTSSIDO1NPC1
SCHEMBL5543932 0.82 SYK (0.46) SYKCTSKCTSSIDO1NPC1
SCHEMBL14365151 0.79 CHRM1 (0.48) CHRM1CHRM3CHRM2NPC1RAB9A
SCHEMBL5548756 0.78 SYK (0.45) SYKCTSKCTSSIDO1NPC1
SCHEMBL1520746 0.76 CTSK (0.49) SYKCTSKCTSSIDO1ATM
SCHEMBL5545783 0.76 CHRM1 (0.45) CHRM1CHRM3CHRM2NPC1RAB9A
SCHEMBL14365161 0.76 CHRM1 (0.44) CHRM1CHRM3CHRM2CTSKCTSS
SCHEMBL14365125 0.75 CHRM1 (0.44) CHRM1CHRM3CHRM2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7301018-B2 Probe for mass spectrometry of liquid sample JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2007-11-27 US disclosed
US-20040142378-A1 Probe for mass spectrometry of liquid sample JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2004-07-22 US disclosed
US-20040031122-A1 Wiping device VALEO WISCHERSYSTEME GMBH (DE) 2004-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142378-A1 Probe for mass spectrometry of liquid sample MRPS22, MRPS27, MRPS23 CHRM1 1278/4885CHRM3 1483/4885CHRM2 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.